Latest news
Loading news…
ADEL is developing therapeutic and diagnostic agents for neurological diseases, particularly Alzheimer's disease.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
6
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Seoul, Seoul-t'ukpyolsi, South Korea
6
professional contacts at ADEL
Contact execs at ADEL →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to ADEL
Loading news…
FAQs about ADEL
People who checked this page also checked these
Browse the full Acquirezy directory.